转录抑制剂BCL11A在红状腺细胞中
Ge Zheng1,2, Stuart H Orkin3,4
1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Advances in experimental medicine and biology
|July 17, 2024
概括
降低BCL11A的调节会重新激活胎儿血红蛋白 (HbF) 的产生,通过向关键的遗传调节器,为状细胞疾病 (SCD) 和β-血症提供了一个有前途的治疗策略.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- BCL11A是一种转录因子,调节从胎儿血红蛋白 (HbF) 转换为成人血红蛋白 (HbA).
- 全基因组关联研究将BCL11A与红状腺细胞中的HbF调节联系起来,尽管它在淋巴发育中的作用已知.
- BCL11A作为马环球蛋白基因表达的抑制剂,对HbF产生至关重要.
研究的目的:
- 研究BCL11A在红色素细胞中的作用及其作为血红蛋白病的治疗点的潜力.
- 为了识别和描述控制BCL11A表达在红色素细胞中的调节元素.
- 探索基因编辑策略,以调节在状细胞病 (SCD) 和β-thalassemia的背景下BCL11A活动.
主要方法:
- 利用CRISPR/Cas9基因编辑来准BCL11A基因中的红色素特异性增强剂.
- 研究了增强剂内GATA结合部位的功能,这对BCL11A表达至关重要.
- 针对临床试验的先进指导RNA向,涉及对造血干细胞/原生细胞 (HSPC) 的ex vivo编辑.
主要成果:
- 在BCL11A增强剂中GATA结合部位的破坏导致HbF的强有力的重新激活.
- 在工程状细胞疾病小鼠模型中,红状腺特异性BCL11A损失挽救了表型.
- 临床试验证明了用于SCD和β-thalassemia治疗的HSPCs的ex vivoCRISPR编辑的可行性.
结论:
- 降低BCL11A的调节是一种可行的治疗策略,用于SCD和β-thalassemia.
- 针对BCL11A增强剂,特别是GATA结合部位,有效地重新激活HbF.
- 对HSPCs的ex vivo CRISPR基因编辑显示出治疗血红蛋白病变的前景,目前正在努力改善获取,降低成本,并探索体内方法.
相关概念视频
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Transcription Factors
75.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K


